WEBINAR Introducing human iPSC derived muscle cells for research and drug discovery Dr Will Bernard, Senior Scientist (bit.bio), Dr Luke Flatt, Senior Scientist (Charles River). 2020 Summary Introducing the first human iPSC-derived skeletal myocyte Learn how...
WEBINAR Advances in cellular reprogramming: from stem cells to printed tissues Prof Hagan Bayley, University of Oxford & Dr Mark Kotter, Founder & CEO bit.bio. 2020 Summary A scalable technology platform capable of producing consistent batches of every human...
Leading clinical immunotherapies developer Ramy Ibrahim joins bit.bio as Chief Medical Officer
bit.bio CEO discusses opti-ox™ technology and the work of bit.bio on BBC Click
Can We Recreate Every Human Cell Type In The Body? This UK Startup Thinks So
Bit.Bio: British firm cracks code for stem cells
bit.bio joins forces with maths institute to find the ‘operating system of life’